香港股市 將在 9 小時 11 分鐘 開市

ZY Jan 2024 10.000 put

OPR - OPR 延遲價格。貨幣為 USD。
加入追蹤清單
6.480.00 (0.00%)
市場開市。 截至 10:09AM EDT。
全螢幕
正在載入互動式股價圖表...
  • Benzinga

    Ginkgo Bioworks Expands Horizontal Synthetic Biology Platform With This Stock Deal

    Ginkgo Bioworks Holdings Inc (NYSE: DNA) agreed to acquire Zymergen Inc (NASDAQ: ZY) in an all-stock transaction. Zymergen stockholders will receive 0.9179 shares of Ginkgo's Class A common stock for each Zymergen share. The deal values Zymergen at approximately $300 million and would provide Zymergen shareholders about 5.25% pro forma ownership of Ginkgo. Ginkgo plans to integrate Zymergen's core automation and software technologies for scaling strain engineering capacity into its foundry, incl

  • Benzinga

    Zymergen Highlights Early Results From Work On Potential COVID-19 Drug Candidate

    Zymergen Inc (NASDAQ: ZY) announced early results from its work on infectious disease, discovering several potential novel hits against malaria, tuberculosis, and COVID-19 targets. Hits for PfAPP, a critical target in the treatment of malaria, are now being advanced for validation, with hits for an emerging COVID-19 target, PLpro, expected to follow. The multi-target infectious disease program is supported by a Bill & Melinda Gates Foundation grant, enabling Zymergen to identify novel hits for a

  • Insider Monkey

    10 Best Biotech Stocks Under $20 in Cathie Wood’s Portfolio

    In this article, we discuss the 10 best biotech stocks under $20 in Cathie Wood’s portfolio. If you want to skip our detailed analysis of these stocks, go directly to 5 Best Biotech Stocks Under $20 in Cathie Wood’s Portfolio. ARK Investment Management sits on a portfolio value of nearly $42 billion as of Q3, compared […]